je.st
news
Tag: heavily
California schools rely too heavily on police for disciplinary issues, ACLU says
2016-10-19 20:53:00| American School & University
Report from civil rights group says police presence in schools disproportionately punishes students of color and those with disabilities. read more
Tags: issues
california
says
schools
Debt woes 'weigh heavily' on young people, survey finds
2016-08-30 01:00:11| BBC News | Business | UK Edition
More than a third of 18 to 24-year-olds have debts of almost 3,000 and experience significant concerns about their finances, a survey finds.
Tags: people
young
survey
debt
Mary Robinson: Ethiopia heavily impacted by climate change despite negligible emissions
2016-07-03 16:56:00| Climate Ark Climate Change & Global Warming Newsfeed
BreakingNews: Former president of Ireland Mary Robinson has said it is unfair that Ethiopians are suffering the worst effects of climate change as 10 million people are hit by food shortages following the worst drought in 50 years. The UN special envoy for climate change and the El Nino weather pattern is spending three days in the country this week after widespread failure of rains and flash floods in the region over the last year. Mrs Robinson, former UN high commissioner for human rights, said Ethiopia...
Tags: change
mary
climate
robinson
KEYTRUDA (pembrolizumab) Shows Overall Response Rates of 73 to 83 Percent, with Complete Response Rates of 27 to 30 Percent, in Heavily Pre-treated Patients with cHL, in Update to Study KN-087
2016-06-06 14:00:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Findings Support Initiation of Phase 3 Pivotal Study (KEYNOTE-204) Evaluating KEYTRUDA Versus Brentuximab Vedotin in Relapsed or Refractory cHL KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first-time presentation of findings from KEYNOTE-087, the phase 2 study investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, as a monotherapy in patients with relapsed or refractory classical Hodgkin lymphoma (cHL). These data will be presented today at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from 8:00 11:30 a.m. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orAn Phan, 908-255-6325orInvestors:Teri Loxam, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
REITs Lean More Heavily on JV Partner Capital
2016-04-13 09:00:00| National Real Estate Investor
Many REITs are trading below their net asset values, which makes accessing capital in public markets more expensive. read more
Tags: partner
capital
heavily
lean
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] next »